¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1) : 2021-11-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1) : 2021-11-03
±³À°ÀÏÀÚ : 2021-11-03
±³À°Àå¼Ò : ¼­¿ï COEX 203È£ ¿Ü  
±³À°ÁÖÁ¦ : Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1)
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : ±èÁöÇü
¿¬¶ôó : 02-573-8190  
À̸ÞÀÏ : urology@urology.or.kr      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 110,000¿ø      
ºñ°í ºÀÁ÷ȸ¿ø: 110,000¿ø/°³¿øȸ¿ø: 110,000¿ø/±ºÀÇ°ü,°øº¸ÀÇ: 66,000¿ø/Àü°øÀÇ: 66,000¿ø/Ÿ°úÀü¹®ÀÇ:120,000¿ø/Ÿ°úÀü¹®ÀÇ(1Àϵî·Ï):88,000¿ø/°£È£»ç: 66,000¿ø/°£È£»ç(1Àϵî·Ï):33,000¿ø/¿¬±¸¿ø:66,000¿ø/Á¦¾àȸ»ç ¹× ÀÇ·á±âȸ»ç: 120,000¿ø *»çÀüµî·Ï ±âÁØ      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-03 D (Room.203) 10:00~10:30 Countermeasures against CCTV Installation in operating room  ¹ÚÈ«ÁÖ(°­¿øÀÇ´ë) 
±³À°½Ã°£ 11-03 D (Room.203) 10:30~11:00 Coping with the trend of institutionlization of physician`s assistant nurse  ±èų²(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-03 D (Room.203) 11:00~11:30 Preparation and completion of appropriate surgical informed consent  ¼ÛÇÊÇö(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 11-03 D (Room.203) 11:30~12:00 Proper response to medical assault and verbal abuse  ÃÖżö(°æÈñÀÇ´ë) 
½Ä»ç 11-03 B,D,E 12:30~13:00 ½Ä»ç  () 
±³À°½Ã°£ 11-03 C (Room.202) 13:00~13:05 Remodeling of tumor microenvironment in lung metastatic sites by oncolytic vaccinia virus in pulmonary metastatic orthotopic renal cell carcinoma murine model  ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø) 
±³À°½Ã°£ 11-03 C (Room.202) 13:05~13:10 BRCA1/2 and ATM mutated metastatic prostate cancers may present with low serum PSA  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:10~13:15 VNTR polymorphism in the breakpoint region of ABL1 and bladder cancer  ±èų²(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:15~13:20 Optical Genome Mapping Identifies Complex Genomic Rearrangement in Prostate Cancer Needle Biopsy Sample  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:20~13:25 Genomic features associated with therapeutic responsiveness of immune checkpoint blockades in patients with metastatic renal cell carcinoma  ±èÁرÔ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:25~13:30 Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma  ±¸¿µ¶õ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:30~13:35 Development and Validation of a Method for Detection of Circulating Tumour DNA in Muscle-Invasive Bladder Cancer  Ruchira Nandurkar(Eastern Health Clinical School, Monash University, Australia1Eastern Health, Australia) 
±³À°½Ã°£ 11-03 C (Room.202) 13:35~13:40 Carboxyl esterase-TRAIL expressing human adipose stem cells inhibit tumor growth in castration resistant prostate cancer bearing mice with less toxicity.  ¼ÛÀ±¼·(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:40~13:45 The anti-metastatic effect of PDK4 inhibition in bladder cancer via Akt, ERK, and JNK signaling pathway.  ÀÌ»óÈñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:45~13:50 RPL9 gene expression could predict the BCG response in non-muscle invasive bladder cancer patients  ¹ÚÇö¹Ì(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:50~13:55 Urinary exosome microRNA signatures as a non-invasive prognostic biomarker for prostate cancer  ½Åµ¿È£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 13:55~14:00 Åä·Ð  () 
±³À°½Ã°£ 11-03 C (Room.202) 14:00~14:05 Adipose-derived stem cells therapy in a rat model with urethral stricture/fibrosis  °í±¤Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:05~14:10 Therapeutic efficacy of human embryonic stem cell-derived multipotent stem cells in diabetic detrusor underactivity: A preclinical study  ·ùä¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:10~14:15 A Novel Therapeutic Strategy using Ultrasound Mediated-Microbubbles Drug Delivery System to treat Prostatic Hyperplasia  ÀÌÀç±Ù(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:15~14:20 Enhanced efficacy of Wharton¡¯s jelly mesenchymal stem cells and their derived Extracellular vesicles in interstitial cystitis/bladder pain syndrome mice model treatment  ±è¾Æ¶÷(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:20~14:25 A preclinical study of human embryonic stem cell-derived mesenchymal stem cells for treating detrusor underactivity by chronic bladder ischemia  ½ÅÁ¤Çö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:25~14:30 Therapeutic effects of Primed Fresh OCT4 enriched mesenchymal stem cells in radiation cystitis mouse model  ½ÅÁ¤Çö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:30~14:35 Metformin and Sildenafil Protects against Ischemia/Reperfusion-Induced Injury in Rat Urinary Bladders  ÀÌÀç±Ù(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:35~14:40 Extracorporeal Shockwave Therapy Improves CP/CPPS by Down-regulating NLPR3 Inflammasome in a Prostatitis Rat Model  ½Åµ¿È£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:40~14:45 Differentially expressed mRNA in streptozotocin induced diabetic bladder using QuantSeq next generation sequencing  ¼ÛÀ±¼·(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:45~14:50 First 3D vascular map of a rabbit urethra visualized by a photoacoustic catheter probe  ÇÏÀ±¼®(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:50~14:55 Development of an automatic interpretation algorithm for uroflowmetry results: application of artificial intelligence  ¿¹Ã¢Èñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 14:55~15:00 Åä·Ð  () 
±³À°½Ã°£ 11-03 C (Room.202) 15:00~15:05 Anticancer effect of GLUT1 targeting agent against kidney cancer  ÀÌÁö¿µ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:05~15:10 Systemic effects of oncolytic vaccinia virus in prevention and regression of lung metastasis in renal cell carcinoma  ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø) 
±³À°½Ã°£ 11-03 C (Room.202) 15:10~15:15 Regulation of hippo-pathway via epigenetic control in RCC  È«¼ºÈÖ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:15~15:20 Inhibition of metabolic symbiosis by AUBP in RCC  Çϳª°æ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:20~15:25 The combination of sunitinib and metformin promotes autophagy of RCC  Çϳª°æ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:25~15:30 Metformin enhanced everolimus sensitivity by regulating the mitochondrial dynamic in RCC.  È²ÇöÁö(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:30~15:35 Ginsenoside Rh2 strengthens cell cycle arrest by sunitinib in renal cell carcinoma  È²ÇöÁö(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:35~15:40 Tubular damage marker is a predictive factor for distinguishing pathological upstaged renal cell carcinoma  ÇÑÀåÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:40~15:45 Lymphocyte-activation gene 3 (LAG-3) + tumor infiltrating immune cells in clear cell renal cell carcinoma: Clinical correlates and association with PD-L1 + tumors  ÀÌÂùÈ£(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:45~15:50 Deep learning-based metastasis prediction model for kidney cancer patients after nephrectomy  ±èµ¿¿ø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:50~15:55 Artificial Intelligence Model Predicts Postoperative Renal Function and Acute Kidney Injury Severity  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 15:55~16:00 Åä·Ð  () 
±³À°½Ã°£ 11-03 C (Room.202) 16:00~16:05 Liposome-Encapsulated Bacillus Calmette–Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo study  ½ÉÀçÇå(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:05~16:10 Neoadjuvant versus adjuvant chemotherapy in bladder cancer: A nationwide cohort Study  ÇãűÔ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:10~16:15 Comparison of Functional and Oncological Outcomes between Reproductive Organ-Sparing Radical Cystectomy and Standard Radical Cystectomy in Women: A Retrospective Study  ¹ÚÀç¼®(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:15~16:20 Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy (RARC)  ¿¹Ã¢Èñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:20~16:25 Expression of VISTA on tumor‑infiltrating immune cells correlated with short intravesical recurrence in non‑muscle‑invasive bladder cancer  ¼­¿øÀÍ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:25~16:30 Prognostic value of the endothelial activation and stress index in upper tract urothelial cancer patients who underwent radical nephroureterectomy.  ±¸Áø¼®(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:30~16:35 Acidic urine might confer optimized tumor microenvironment for bladder cancer progression  ÇÑÀåÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:35~16:40 Impact of Preoperative Chemotherapy on Pathologic Nodal Status in Muscle-Invasive Bladder Cancer: Optimal Lymphadenectomy in the Preoperative Chemotherapy Era  ÀÌ¿øö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:40~16:45 The effect of antithrombotic therapy on T stage and grade of bladder cancer at the time of diagnosis  ±è°æȯ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:45~16:50 Catheter-associated urinary tract infections in bladder cancer patients undergone radical cystectomy  Å¹ü½Ä(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:50~16:55 Clinical determinant of early or later recurrence of pTa bladder cancer following TURB  Á¤½Âȯ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-03 C (Room.202) 16:55~17:00 Åä·Ð  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1) : 2021-11-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿ëÀμ¼ºê¶õ½ºº´¿ø 2021 ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãß°èÇмú´ëȸ (1ÀÏÂ÷) : 2021-11-04
´ÙÀ½±Û Àü¹® ±âµµ°ü¸® ½Ã¹Ä·¹ÀÌ¼Ç ÈÆ·Ã : 2021-11-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 46 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 23 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 26 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷